ReviewFrontiers in endocrinology2018

Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs.

Barbara Capuani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.